Sarah
Sarah All, White River Junction, VT US
Patent application number | Description | Published |
---|---|---|
20110177573 | Microbial Treatment of Lignocellulosic Biomass - Aspects of the present invention relate to methods of microbially treating lignocellulosic biomass using cellulose- and/or hemicellulose-degrading bacteria. In certain embodiments, the microbially treated material is then subjected to thermal and/or chemical pretreatment. In tandem with the microbial treatment the thermal and/or chemical pretreatment may result in the production of fewer degradation products, thereby allowing for higher overall yields of ethanol per ton of starting biomass. | 07-21-2011 |
Sarah Angelos, Corvallis, OR US
Patent application number | Description | Published |
---|---|---|
20100284924 | NANO-DEVICES HAVING IMPELLERS FOR CAPTURE AND RELEASE OF MOLECULES - A nanodevice has a containment vessel defining a storage chamber therein and defining at least one port to provide transfer of molecules to or from the storage chamber, and a plurality of impellers attached to the containment vessel. The plurality of impellers are of a structure and are arranged to substantially block molecules from entering and exiting the storage chamber of the containment vessel when the impellers are static and are operable to impart motion to the molecules to cause the molecules to at least one of enter into or exit from the storage chamber of the containment vessel. | 11-11-2010 |
20100310465 | NANO-DEVICES HAVING RELEASABLE SEALS FOR CONTROLLED RELEASE OF MOLECULES - A nanodevice has a containment vessel defining a storage chamber therein and defining at least one port to provide access to and from said storage chamber, and a stopper assembly attached to the containment vessel. The stopper assembly has a blocking unit arranged proximate the at least one port and has a structure suitable to substantially prevent material after being loaded into the storage chamber from being released while the blocking unit is arranged in a blocking configuration. The stopper assembly is responsive to the presence of a predetermined stimulus such that the blocking unit is released in the presence of the predetermined stimulus to allow the material to be released from the storage chamber. The predetermined stimulus is a predetermined catalytic activity that is suitable to at least one of cleave, hydrolyze, oxidize, or reduce a portion of the stopper assembly, and the nanodevice has a maximum dimension of about 1 μm. | 12-09-2010 |
Sarah Baker, Pleasanton, CA US
Patent application number | Description | Published |
---|---|---|
20100209531 | Oxides for Wound Healing and Body Repair - The invention provides a homogeneous composition comprising a hemostatically effective amount of a charged oxide, wherein the composition has an isoelectric point, as measured in calcium chloride, below 7.3 or above 7.4. Typically, the charged oxide is selected from the group consisting of silaceous oxides, titanium oxides, aluminum oxides, calcium oxides, zinc oxides, nickel oxides and iron oxides. In some embodiments, the composition further comprises a second oxide selected from the group consisting of calcium oxide, sodium oxide, magnesium oxide, zinc oxide, phosphorus oxide and alumina. In a typical embodiment of the invention, the charged oxide is silaceous oxide, the second oxide comprises calcium oxide and the ratio, by molar ratio, of silaceous oxide to calcium oxide is 0.25 to 15. Optionally, the composition further comprises phosphorous oxide. Also described are methods of making and using such compositions. | 08-19-2010 |
20120308639 | Mesocellular Oxide Foams as Hemostatic Compositions and Methods of Use - The present invention relates to hemostatic compositions comprising a mesocellular oxide foam and, optionally, a biologically active agent such as a procoagulant, as well as devices and methods of use to promote blood clotting. | 12-06-2012 |
Sarah Bartulis, Emeryville, CA US
Patent application number | Description | Published |
---|---|---|
20100048547 | PI 3-KINASE INHIBITORS AND METHODS OF THEIR USE - Phosphatidylinositol (PI) 3-kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases, including proliferative diseases, inflammatory and obstructive airways diseases, allergic conditions, autoimmune and cardiovascular diseases. | 02-25-2010 |
20100075965 | PI3 KINASE INHIBITORS AND METHODS OF THEIR USE - Phosphatidylinositol (PI) 3 kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, phospholipid kinases, G-protein coupled receptors, and phosphatases. | 03-25-2010 |
20100249126 | PYRIMIDINE DERIVATIVES USED AS PI-3-KINASE INHIBITORS - Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases. | 09-30-2010 |
20120225859 | PYRIMIDINE DERIVATIVES USED AS PI-3 KINASE INHIBITORS - Phosphatidylinositol (PI) 3-kinase inhibitor compounds (I), their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases. | 09-06-2012 |
Sarah Bedair, Bethesda, MD US
Patent application number | Description | Published |
---|---|---|
20110180884 | METHODS, APPARATUSES, AND SYSTEMS FOR MICROMECHANICAL GAS CHEMICAL SENSING CAPACITOR - A capacitive chemical sensor, along with methods of making and using the sensor are provided. The sensors described herein eliminate undesirable capacitance by etching away the substrate underneath the capacitive chemical sensor, eliminating most of the substrate capacitance and making changes in the chemical-sensitive layer capacitance easier to detect. | 07-28-2011 |
20120266770 | APPARATUS AND METHOD FOR SUSPENSION WICKING OF NANOPARTICLES INTO MICROCHANNELS - A method of forming a device on a substrate comprising creating a depository and at least one attached capillary; the depository being of millimeter scale; providing a liquid containing particles in the range 1 nanometer to 1 millimeter; depositing into the depository the liquid containing particles which flows into at least one capillary by capillary action; evaporating the liquid such that the particles form an agglomerate beginning at the end of the at least one capillary with a substantially uniform distribution of the particles within the agglomerate; which is used to form a device. A microelectronic integrated circuit device comprising a substrate; a depository coupled to said substrate, the depository being formed by at least one wall adjacent to the substrate; at least one capillary channel coupled to at least one depository that is formed by walls adapted to be filled with a liquid (by capillary action) comprising nanoparticles. | 10-25-2012 |
20140070902 | BINARY BI-PHASE SHIFT MODULATOR - A binary bi-phase shift modulator having an input piezoelectric transducer and an output piezoelectric transducer connected in series between a radio frequency input and a radio frequency output. A fixed DC pole voltage having a first polarity is connected to one of the transducers. A DC switched pole voltage is connected to the other transducer which switches between the pole voltage of the first polarity arid a pole voltage of the opposite polarity m accordance with a dinar data signal The polarity of the radio frequency input relative to the radio frequency output varies as a function of the polarity of the DC switched pole voltage. | 03-13-2014 |
Sarah Beeby, London GB
Patent application number | Description | Published |
---|---|---|
20110130697 | WOUND TREATMENT DEVICE AND METHOD - A method of aiding the healing of a wound in a limb of a patient, the method comprises elevating the limb to a substantially horizontal or greater than horizontal angle, and applying electrical signals across the wound to stimulate healing. Also, a method and device for aiding the healing of a wound in a limb of a patient operates to generate electrical signals for a period of time at repeated intervals in accordance with a treatment regime for application of the electrical signals to electrodes applied around the wound to apply the electrical signals across the wound; to detect motion and/or elevation of the limb; and to control the application of the electrical signals to the electrodes in response to the detection to modify the treatment regime to preferentially apply the electrical signals across the wound when the limb is active and/or elevated. Further, a method and device for aiding the healing of a wound in a limb of a patient operates to generate electrical signals for a period of time at repeated intervals in accordance with a treatment regime for application to electrodes applied around the wound to apply the electrical signals across the wound; and to warn the patient before the electrical signals are going to be applied to across the wound to enable the patient to take required action in compliance with the treatment regime. | 06-02-2011 |
Sarah Caplener, Santa Cruz, CA US
Patent application number | Description | Published |
---|---|---|
20110082807 | SOCIAL BROADCASTING USER EXPERIENCE - A method of providing user participation in a social broadcast environment is disclosed. A network communication is received from a user of a broadcast that includes a preference data indicating a preference of the user that a promoted content be included in the broadcast. Via a responsive network communication, a feedback data is provided to the user that includes a predicted future time at which the promoted content may be included in the broadcast. | 04-07-2011 |
20130218668 | DYNAMIC SELECTION OF ADVERTISING CONTENT IN A SOCIAL BROADCAST ENVIRONMENT - A method of determining advertising content to be included in a broadcast is disclosed. An inclusion criterion is received for each of a plurality of items of advertising content to be used to determine one or both of whether and how that item of advertising content is to be included in a broadcast. Stored user profile data associated with a plurality of users who provided within an observation period an indication that the user was consuming the broadcast is processed, and the respective inclusion criteria of the items of advertising content, to select and integrate into the broadcast selected ones of the items of advertising content. | 08-22-2013 |
20130253934 | SOCIAL BROADCASTING USER EXPERIENCE - A method of providing user participation in a social broadcast environment is disclosed. A network communication is received from a user of a broadcast that includes a preference data indicating a preference of the user that a promoted content be included in the broadcast. Via a responsive network communication, a feedback data is provided to the user that includes a predicted future time at which the promoted content may be included in the broadcast. | 09-26-2013 |
20130322609 | PROVIDING MISSED CALL AND MESSAGE INFORMATION - Information associated with messages and/or missed calls is provided to a subscriber. Calls received but not answered by the subscriber may be monitored. Each monitored call is classified as one of a missed call and a message. The monitored calls may be summarized based on a customizable rule set to create a summary. The summary is provided to the subscriber via, for example, a voice notification. | 12-05-2013 |
20130340016 | SOCIAL BROADCASTING PLATFORM - A method of social broadcasting is disclosed. A metadata is generated indicating items of content expected to be included in a broadcast and for each item of content a manner in which the item of content is to be included in the broadcast. The metadata is provided and at least a subset of said items of content to a broadcast platform in one or more network communications sent to the broadcast platform via a network interface. A method of social broadcasting is disclosed. A metadata is received via a server interface indicating items of content expected to be included in a broadcast and for each item of content a manner in which the item of content is to be included in the broadcast. At least a subset of said items of content is stored in a media cache. Said items of content are used to assemble in the manner indicated by said metadata, and to provide as output for broadcast to the station interface, a broadcast stream, including by responding dynamically to subsequently received metadata indicating a change in one or both of (1) said items of content expected to be included in a broadcast and (2) the manner in which one or more of said items of content is or are to be included in the broadcast. | 12-19-2013 |
Sarah Cohen, Ashdod IL
Patent application number | Description | Published |
---|---|---|
20080271223 | COMBINATION OF AN UNDERSHIRT AND A FOUR-CORNERED GARMENT WITH FRINGES - The present invention provides an undershirt provided with means for releasable attachment thereto of a component of a four-cornered garment with fringes as well as providing a four-cornered garment with fringes having a releasable attachment means for attachment thereof to a garment. | 11-06-2008 |
Sarah Corey, Uxbridge CA
Patent application number | Description | Published |
---|---|---|
20090266274 | EXPANDABLE OVERBED TABLE - An overbed table with a primary table top may be expanded through the deployment of a secondary table top. Advantageously, by appropriately arranging the position of the manner by which the secondary table top is mounted to the overbed table, the top surface of the secondary table top can occupy the same plane as the top surface of the primary table top. Additionally, the overbed table may incorporate further features including equipment rails, power receptacles, networking receptacles and a computing device. | 10-29-2009 |
Sarah Cotsen, New York County, NY US
Patent application number | Description | Published |
---|---|---|
20080282295 | Pausing and Resuming Content Streaming On Wireless Devices - In one embodiment, a communication system transmits video content in a looped manner using wireless communications to a cell phone capable of playing the content in a streaming manner. The cell phone is capable, after the playing of the received video content has been interrupted during a current transmission of the content, of resuming play of the content during a subsequent transmission of the looped content, based on the timing of the interruption. The timing of the interruption is compared to a schedule of content transmissions to determine when to resume the playing of the content, e.g., to enable the playing to resume from the location of the interruption. | 11-13-2008 |
Sarah Cousty, Toulouse FR
Patent application number | Description | Published |
---|---|---|
20090035196 | DEVICE FOR GASEOUS PLASMA STERILIZATION - A device for producing a gas plasma by ionisation of a gas using a microwave source of determined nominal power (P | 02-05-2009 |
Sarah Doernberg, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20100143379 | MIF AGONISTS AND ANTAGONIST AND THERAPEUTIC USES THEREOF - The present invention relates to methods and compositions for selecting a subject for treatment with an agonist or antagonist of macrophage migration inhibitory factor (MIF), identifying a subject at risk for developing a disease associated with high or low MIF expression, predicting the severity of a disease associated with high or low MIF expression in a subject, and for predicting whether a subject is susceptible to a disease associated with high or low MIF expression. The invention also provides novel methods of diagnosing a patient for a disease associated with high or low MIF expression. Also provided are methods for treating a subject having a disease or disorder associated with high or low MIF expression. | 06-10-2010 |
Sarah Dreikorn, Scotch Plains, NJ US
Patent application number | Description | Published |
---|---|---|
20100292085 | Methods and compositions for characterization of HSD1 inhibitors - One aspect of the present invention relates to methods of identifying cortisone response signature gene sets and methods of using the identified gene sets to identify compounds that modulate HSD1 activity. In some embodiments, methods are provided to use cortisone response gene sets to estimate the HSD1 activity. Another aspect of the present inventive relates to methods for identification of off-target signature gene sets that can be used to estimate HSD1 compound induced off-target activity and methods for classification of compounds that modulate HSD1 activity. Another aspect of the present invention relates to cell lines that over-expresses HSD1 and methods of use thereof. Additional embodiments of the of the invention are described in the specification provided herein. The contents of this ABSTRACT are not intended to in anyway limit the scope of the invention claimed herein. | 11-18-2010 |
Sarah Leila Du Fou, Hitchen GB
Patent application number | Description | Published |
---|---|---|
20080305114 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 12-11-2008 |
20090175857 | Human Antibodies That Bind Human IL-12 And Methods For Producing - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 07-09-2009 |
20090269302 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 10-29-2009 |
20090311241 | Human antibodies that bind human IL-12 and methods for producing - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 12-17-2009 |
20110123544 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 05-26-2011 |
20120201831 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 08-09-2012 |
20120213792 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 08-23-2012 |
20120244168 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 09-27-2012 |
20120308514 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 12-06-2012 |
Sarah Earley, Dublin IE
Patent application number | Description | Published |
---|---|---|
20110097806 | METHOD OF ASSESSING CANCER STATUS IN A BREAST CANCER PATIENT - A method of assessing recurrence status in a breast cancer patient comprises a step of assaying a biological sample from the patient for a level of a biomarker selected from S100β or HOX-C1I, wherein positive detection of one or both of the biomarkers is indicative of a positive recurrence status. Suitably, the method is a method of prognosis of poor disease free survival in a breast cancer patient, wherein positive detection of one or both of the biomarkers is indicative of poor disease survival. The method may also be a method of diagnosis of recurrence, wherein positive detection of circulating S100β is a diagnostic variable of recurrence. The method of diagnosis is carried out on a patient who is undergoing first line therapy and/or a patient who has had surgery to remove a primary breast tumour. | 04-28-2011 |
Sarah Fashena, Hackensack, NJ US
Patent application number | Description | Published |
---|---|---|
20090088327 | Method for sequencing a polynucleotide template - The invention relates to methods for pairwise sequencing of a double-stranded polynucleotide template, which methods result in the sequential determination of nucleotide sequences in two distinct and separate regions of the polynucleotide template. Using the methods of the invention it is possible to obtain two linked or paired reads of sequence information from each double-stranded template on a clustered array, rather than just a single sequencing read from one strand of the template. | 04-02-2009 |
Sarah Follmann, Newcastle Upon Tyne GB
Patent application number | Description | Published |
---|---|---|
20110011640 | INSULATING MEDIUM AND ITS USE IN HIGH VOLTAGE DEVICES - An insulating composition for use in high voltage devices is formed from a soft dielectric casting compound, such as a silicone gel, comprising ferroelectric particles such as barium titanate dispersed within it. Low levels of particles, from 1% to 20% by volume of the insulating composition, are highly effective yet do not cause excessive thickening of the soft dielectric casting compound when it is in its liquid state. The insulating composition is particularly effective for coating, enrobing or encapsulating alternating high voltage devices such as power electronics devices in order to prevent electrical discharge. | 01-20-2011 |
Sarah Freemantle, Hanover, NH US
Patent application number | Description | Published |
---|---|---|
20100010072 | MICRORNA BIOMARKERS FOR HUMAN BREAST AND LUNG CANCER - The present invention relates to novel molecular markers for diagnosis and classification of human breast cancer and lung cancer. | 01-14-2010 |
20130296399 | microRNA Biomarkers for Human Breast and Lung Cancer - The present invention relates to novel molecular markers for diagnosis and classification of human breast cancer and lung cancer. | 11-07-2013 |
Sarah Gallini, Finale Emilia IT
Patent application number | Description | Published |
---|---|---|
20080283053 | MEDICAL HEAT AND MOISTURE EXCHANGER (HME) - An HME (heat and moisture exchanger) ( | 11-20-2008 |
20090205659 | DEVICE FOR DETECTING RELATIVE HUMIDITY IN A RESPIRATORY CIRCUIT - A device for detecting the relative humidity in a respiratory circuit is provided which includes a housing closed towards the outside by a transparent element, and towards the inside by a membrane permeable to the humidified gas passing through the equipment to which the device is applied and wherein the housing includes a humidity indicator element. | 08-20-2009 |
20090233350 | RESPIRATORY APPARATUS WITH A BIOBURDEN INDICATOR - A respiratory apparatus includes a bioburden indicator, having an input valve for the entry of air to be analysed, an element for bioburden analysis, and a suction valve suited to be connected to a suction system to suck up the air to be analysed. | 09-17-2009 |
Sarah Gerlo, Gent BE
Patent application number | Description | Published |
---|---|---|
20090029999 | Synephrine derivatives useful as anti-inflammatory agents - This invention provides compounds having the structural formula: | 01-29-2009 |
Sarah Germana, Rome IT
Patent application number | Description | Published |
---|---|---|
20100327225 | PACKAGED PARTICULATE BLEACHING COMPOSITIONS - The present invention relates to a packaged particulate bleaching composition the composition comprising: | 12-30-2010 |
20100331229 | BLEACHING COMPOSITIONS COMPRISING A PERFUME DELIVERY SYSTEM - Particulate bleaching composition comprising a bleaching system, as a first essential component, which comprises oxygen bleach, a bleach activator and a perfume delivery system. Such perfume delivery system is preferably chosen among an amine reaction product containing perfume or an encapsulated perfume made of starch. | 12-30-2010 |
20130005635 | BLEACHING COMPOSITIONS COMPRISING A PERFUME DELIVERY SYSTEM - Particulate bleaching composition comprising a bleaching system, as a first essential component, which comprises oxygen bleach, a bleach activator and a perfume delivery system. Such perfume delivery system is preferably chosen among an amine reaction product containing perfume or an encapsulated perfume made of starch. | 01-03-2013 |
20130005636 | BLEACHING COMPOSITIONS COMPRISING A PERFUME DELIVERY SYSTEM - Particulate bleaching composition comprising a bleaching system, as a first essential component, which comprises oxygen bleach, a bleach activator and a perfume delivery system. Such perfume delivery system is preferably chosen among an amine reaction product containing perfume or an encapsulated perfume made of starch. | 01-03-2013 |
Sarah Grare, South Plainfield, NJ US
Patent application number | Description | Published |
---|---|---|
20110155592 | Implant package - A packaging assembly includes a substantially rigid base having a cavity dimensioned to receive a medical implant, a sleeve positioned in the cavity of the substantially rigid base and defining an opening dimensioned to receive the medical implant, and a skin pack lid sealed over the substantially rigid base to enclose and secure the sleeve within the cavity of the substantially rigid base. The sleeve has a shape substantially similar to a shape of the medical implant and substantially envelopes the medical implant when the medical implant is positioned in the opening of the sleeve. The skin pack lid has a geometry that substantially conforms to the shape of the sleeve. | 06-30-2011 |
Sarah Gredley, Odemira PT
Patent application number | Description | Published |
---|---|---|
20100212200 | Picture frame - An Apparatus for framing and/or hanging a picture ( | 08-26-2010 |
Sarah Harris, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20100216443 | Method and system for mobile call conferencing - A system and method for providing conference calls in a client-server environment is described. In some aspects, conference calling is made possible and efficient for mobile users, including mobile hosts of the conference call who may arrange and set up the conference call easily from a mobile device with the assistance of an application server and/or a call conference server. Also, other mobile users may easily participate in such conference calls from their mobile devices. | 08-26-2010 |
20140269938 | METHOD FOR DECREASING THE BIT RATE NEEDED TO TRANSMIT VIDEOS OVER A NETWORK BY DROPPING VIDEO FRAMES - An aspect of the disclosure is directed to transmitting a reduced stream of encoded video frames. An original stream of encoded video frames is analyzed, a plurality of frames are removed without re-encoding encoded video frames to generate the reduced stream of encoded video frames, and the reduced stream and metadata describing the plurality of removed frames are transmitted. An aspect of the disclosure is directed to creating a new version of an original stream of encoded video frames from a reduced stream of encoded video frames. The reduced stream of encoded video frames is received, the plurality of removed frames is identified based on metadata related to the reduced stream, a plurality of replacement frames are generated, and the plurality of replacement frames are added to the reduced stream of encoded video frames to recreate the new version of the original stream of encoded video frames. | 09-18-2014 |
Sarah Herscovici-Cohen, Zikhron-Yaakov IL
Patent application number | Description | Published |
---|---|---|
20110092831 | NON INVASIVE METHOD AND APPARATUS FOR DETERMINING LIGHT-SLEEP AND DEEP-SLEEP STAGES - A method and apparatus for detecting and distinguishing epochs of deep-sleep from epochs of light-sleep of a subject by sensing by a peripheral pulse signal related to the systemic circulation of the subject, preferably a peripheral arterial tone (PAT) sensor for sensing pulsatile arterial volume changes in a digit (e.g., a finger) of the subject reflecting sympathetic tone variations; analyzing the sensed pulse signals for determining therefrom a number of features, particularly seven specific variables in each of two time periods; and utilizing the results of the analysis for determining whether the epoch detected is a light-sleep epoch or a deep-sleep epoch. | 04-21-2011 |
20110092857 | METHOD AND APPARATUS FOR EXAMINING SUBJECTS FOR PARTICULAR PHYSIOLOGICAL CONDITIONS UTILIZING ACOUSTIC INFORMATION - A method and apparatus for examining a subject for a particular physiological condition according to a technique which utilizes sounds generated by the subject and sensed at a predefined distance from the site of sound generation of the subject, by locating a first sound sensor, e.g., a sound level meter which measures the sound levels in decibels, on a particular region of the subject's body to produce an output corresponding to the sound level sensed thereby; modifying the output of the first sound level meter by a pre-calculated Transfer Function equating its output to that of a second sound level meter located at a predefined distance from the site of sound generation of the subject's body; and utilizing the modified output of the first sound level meter in determining the existence of the particular physiological condition. | 04-21-2011 |
Sarah Humke, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20100119665 | HOME-STYLE MEAT PRODUCT AND METHOD OF PRODUCING SAME - Methods and apparatus are disclosed for producing irregular slices of meat from meat products. Further, a method of mass-producing a home-style meat product with an irregular appearance includes combining whole muscle meat with a mixture having no phosphates and a limited amount of salt. Further, the whole muscle meat mixture is loosely stuffed into casings such that void space is permitted between the individual whole muscles. Once the whole muscle meat has been cooked and cooled, the meat may be sliced on a variety of slicing equipment to create a home-style meat product with an irregular appearance. | 05-13-2010 |
Sarah Hutcherson, Greer, SC US
Patent application number | Description | Published |
---|---|---|
20090320483 | Variable Orifice Plug for Turbine Fuel Nozzle - A fuel nozzle for use about an end cap of a combustor. The fuel nozzle may include a flange attached to the end cap, an aperture extending through the flange, a plug positioned in the aperture, and an orifice positioned within the plug. | 12-31-2009 |
Sarah Ihne, Waiblingen DE
Patent application number | Description | Published |
---|---|---|
20080256722 | METHOD FOR RINSING FABRIC IN A WASHER AND WASHER ADAPTED TO CARRY OUT THIS METHOD - A method of rinsing fabric in a washer having a wash chamber rotatable about a horizontal axis comprises the step of adding water to the wash chamber and spraying the rinse water by recirculating it onto the fabric while spinning the wash chamber at a speed to effect a centrifugal force on the fabric such that the fabric will not tumble within the wash chamber as it spins. The method further comprises at least a last rinsing step in which the rotating speed of the wash chamber is such that the fabric tumbles within the wash chamber and in that the rinsing water is not recirculated and sprayed onto the fabric. | 10-23-2008 |
20120079664 | METHOD FOR CONTROLLING A CYCLE OF OPERATION IN A LAUNDRY TREATING APPLIANCE - A method for controlling a laundry treating appliance having a treating chamber for treating laundry may provide a wash liquid including an enzyme into the treating chamber to effect an enzymatic reaction having at least one constituent product, monitor the concentration of the at least one constituent product, and alter the control of the laundry treating appliance in response to the concentration reaching a plateau. | 04-05-2012 |
Sarah Janboecke, Essen DE
Patent application number | Description | Published |
---|---|---|
20080250559 | Device for the transport and medical care of patients as well as for the provision of emergency medical care in an aircraft - A device for the transport and medical care of patients as well as for the provision of emergency medical care in an aircraft, which can be arranged and permanently installed inside the passenger cabin of an aircraft, and has a stretcher and medical care equipment, and screens the patient from the environment at least partially by means of lateral elements. The device is enveloped on all sides by lateral elements, and forms a separated compartment relative to the passenger cabin, the volume of which can be temporarily enlarged by shifting at least one lateral section between the first, emergency medical care mode, and a second, expanded mode for patient transport, wherein the stretcher can be horizontally arranged within the compartment in the first mode, and space is available for a medical assistant inside the compartment. | 10-16-2008 |
Sarah Jurta, Fairfield, CT US
Patent application number | Description | Published |
---|---|---|
20100153309 | SYSTEM AND METHOD FOR DIMENSIONAL RATING OF MAIL PIECES - Systems and methods for dimensionally rating mail pieces including cards, letters, flats, mailers, packages and parcels using a pointing device such as a digital pen are described. In one illustrative configuration the system includes a digital pen, a three dimensional digital pen pattern device, a computer and a printer for printing evidence of postage payment. A mail piece such as a small parcel is placed on the opened three dimensional digital pen pattern device. The user may select a digital pen pattern command box or may otherwise engage or be prompted to begin measurements. For a rectangular parcel, the user selects a bottom right and then a top left measurement point. The system then calculates the dimensions of the parcel, dimensionally rates it and then accounts for and prints a corresponding postage indicium. | 06-17-2010 |
Sarah Kasperbauer, Cortlandt Manor, NY US
Patent application number | Description | Published |
---|---|---|
20080311642 | Methods of Purifying Chondroitinase and Stable Formulations Thereof - An aspect of the present invention relates to stable formulations of chondroitinase and to methods of purifying chondroitinase. The methods of purifying chondroitinase includes the steps of extracting the enzyme from a cell, separating the chondroitinase from the crude cell extract using cation-exchange chromatography, removing impurities through gel filtration chromatography, and removing endotoxin through an anion-exchange membrane to produce a purified chondroitinase. | 12-18-2008 |
20120207732 | COMPOSITIONS AND METHODS FOR PROMOTING NEURONAL OUTGROWTH - Neural outgrowth in the central nervous system is achieved by administering chondroitinase AC and/or chondroitinase B to degrade chondroitin sulfate proteoglycans that inhibit or contribute to the inhibition of nervous tissue regeneration. | 08-16-2012 |
Sarah Kavassalis, Oakville CA
Patent application number | Description | Published |
---|---|---|
20090233197 | CROSSLINKING OUTER LAYER AND PROCESS FOR PREPARING THE SAME - The presently disclosed embodiments are directed to an improved low wear overcoat for an imaging member having a substrate, a charge transport layer, and an overcoat positioned on the charge transport layer, and a process for preparing the same including combining a binder, a hole transport molecule, a melamine formaldehyde crosslinking agent and an acid catalyst dissolved in an alcohol solvent to form an overcoat solution, and subsequently providing the overcoat solution onto the charge transport layer to form an overcoat layer. | 09-17-2009 |
Sarah Mault, Woodridge, IL US
Patent application number | Description | Published |
---|---|---|
20100072100 | DRY INGREDIENTS CONTAINER - A container comprises a storage compartment and a lid. The storage compartment may be formed of plastic, and may include indicia of measuring. The lid may be removably attached to the storage compartment by a latching mechanism. The latching mechanism may be sturdy enough to contain the contents of the storage compartment, even when those contents are substantially heavy. The contents of the storage compartment may pass through an opening in the lid. The opening may be covered by a removably attached closure, and the closure may include indicia of measuring. The closure may thus be removed from the lid, and used as a measuring device. A scoop may be removably attached to the inside of the lid, may include indicia of measuring, and may be used as a measuring device. | 03-25-2010 |
20100084321 | SIFTER APPARATUS - A sifter apparatus is provided that comprises a body having a crank fastener and a mesh sifter support, a lid configured to be attached to the body, a crank configured to be coupled to the crank fastener, a wire structure configured to be coupled to the crank, a bottom configured to be attached to the body, and a mesh sifter configured to be supported by the mesh sifter support. | 04-08-2010 |
20120223040 | COFFEE CADDY - A support device for moving an item on a surface. A main body includes a panel and a sidewall. A handle assembly engages the main body and includes a first transportation mechanism. The support device includes a resistance portion on the main body for engaging a surface and resisting movement of the support device when in a resistive mode. The handle mechanism lowers the first transportation mechanism to engage the surface and disengage the resistance portion from the surface in a transportive mode to encourage movement of the support device and the item supported thereon. | 09-06-2012 |
20140183322 | MOVABLE SUPPORT DEVICE - A support device for moving an item on a surface. A main body includes a panel and a sidewall. A handle assembly engages the main body and includes a first transportation mechanism. The support device includes a resistance portion on the main body for engaging a surface and resisting movement of the support device when in a resistive mode. The handle mechanism lowers the first transportation mechanism to engage the surface and disengage the resistance portion from the surface in a transportive mode to encourage movement of the support device and the item supported thereon. | 07-03-2014 |
20140299607 | FOOD CARRIER - A food carrier configured for use in decorating, storing, serving and transporting food in a single device. The food carrier includes a turntable base having a body and a rotating member that rotates about a central axis relative to the body, a serving platter configured to removably secure to the turntable base; and a lid configured to engage the turntable base. The turntable base has a plurality of locking mechanisms to secure the rotating member relative to the body. The lid may be lockable to the turntable base by at least one locking mechanism. | 10-09-2014 |
Sarah Mchatton, Salem, VA US
Patent application number | Description | Published |
---|---|---|
20080233093 | Preventing and Reducing Biofilm Formation and Planktonic Proliferation - The present invention relates to methods for preventing and/or reducing biofilm formation and/or planktonic proliferation with one or more selected bacteria strains or bacterial blends. | 09-25-2008 |
Sarah Nataf, Paris FR
Patent application number | Description | Published |
---|---|---|
20110173616 | DETERMINATION AND MANAGEMENT OF VIRTUAL NETWORKS - A method for determination of topology of virtual networks comprises the following steps implemented by a physical node, physical nodes being connected by a physical network and designed to support virtual nodes of these virtual networks: determination of resource parameters defining a physical configuration of the physical network and a physical configuration specific to the physical node and determination of request parameters defining service requests relating to the virtual networks. The method further comprises, in the case of modification of at least one parameter belonging to the group comprising the resource parameters and the request parameters between a current point in time and a preceding point in time, the broadcast of at least the modified parameters within the physical network, the updating of the resource and request parameters as a function of the modified parameters and the determination of topologies for the virtual networks by means of the updated parameters. | 07-14-2011 |
Sarah Netzel-Arnett, Gaithersburg, MD US
Patent application number | Description | Published |
---|---|---|
20090142794 | Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors - The present invention provides methods of specifically targeting compounds to cells overexpressing matrix metalloproteinases, plasminogen activators, or plasminogen activator receptors, by administering a compound and a mutant protective antigen protein comprising a matrix metalloproteinase or a plasminogen activator-recognized cleavage site in place of the native protective antigen furin-recognized cleavage site, wherein the mutant protective antigen is cleaved by a matrix metalloproteinase or a plasminogen activator overexpressed by the cell, thereby translocating into the cell a compound comprising a lethal factor polypeptide comprising a protective antigen binding site. | 06-04-2009 |
20140378654 | MUTATED ANTHRAX TOXIN PROTECTIVE ANTIGEN PROTEINS THAT SPECIFICALLY TARGET CELLS CONTAINING HIGH AMOUNTS OF CELL-SURFACE METALLOPROTEINASES OR PLASMINOGEN ACTIVATOR RECEPTORS - The present invention provides methods of specifically targeting compounds to cells overexpressing matrix metalloproteinases, plasminogen activators, or plasminogen activator receptors, by administering a compound and a mutant protective antigen protein comprising a matrix metalloproteinase or a plasminogen activator-recognized cleavage site in place of the native protective antigen furin-recognized cleavage site, wherein the mutant protective antigen is cleaved by a matrix metalloproteinase or a plasminogen activator overexpressed by the cell, thereby translocating into the cell a compound comprising a lethal factor polypeptide comprising a protective antigen binding site. | 12-25-2014 |
Sarah Nyamuswa, Henderson, NV US
Patent application number | Description | Published |
---|---|---|
20100299960 | FairyJanes: "The Suspender for Stilettos" - Disclosed herein is the FairyJanes invention which is footwear having heel and ankle support for shoes that have a tendency to slip off heel such as pumps, high-heels, mules, backless sandals, etc. The mechanism/strap is a unique invention that is transportable, removable and interchangeable to different shoes. Another highly desirable feature is the ability to rearrange the straps in a variety of configurations in different methods on the instep, arch and ankle of the foot to secure the heeled shoe or boot. FairyJanes are a functional and aesthetic apparatus/accessory for supporting heeled shoes and boots. The mechanism is a one piece strap that goes around the under part of the shoe [the instep and heel] around the heel, crosses over the back of the heel and is secured with a buckle around the ankle. It effectively supports the ankle, arch, instep and heel of the shoe to the foot therefore allowing smooth movement in walking, running with low, medium to high heels and boots during intense activity. It addresses a solution to a fundamental and sometimes hazardous problem of high-heeled shoes slipping off the heel and ankle. There is a left and right FairyJane for the left and right foot. | 12-02-2010 |
Sarah Parish, Oxford GB
Patent application number | Description | Published |
---|---|---|
20110112186 | DIAGNOSTIC METHODS - This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy. | 05-12-2011 |
20120202205 | DIAGNOSTIC METHODS - This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy. | 08-09-2012 |
20150079594 | DIAGNOSTIC METHODS - This invention relates to a method of determining the susceptibility of an individual to statin-induced myopathy, comprising detecting the presence or absence of one or more polymorphisms in the SLCO1B1 gene in a biological sample from an individual, whereby the presence of one or more polymorphisms indicates that the individual has altered susceptibility to statin-induced myopathy. | 03-19-2015 |
Sarah Paris-Mascicki, Monmouth Junction, NJ US
Patent application number | Description | Published |
---|---|---|
20090284601 | APPARATUS FOR INTELLIGENT AND AUTONOMOUS VIDEO CONTENT GENERATION AND STREAMING - A system for automatically capturing an event of interest in a venue is disclosed, comprising a plurality of cameras for capturing video images of the event; and at least one processor communicatively connected to said plurality of cameras and con figured to execute a plurality of modules, said modules comprising a rectification module for combining the video images to form a wide-angle view; at least one of a motion analysis module configured for tracking salient blobs that are not part of a background of the wide-angle view, an activity analysis module configured for extracting temporal and spatial patterns from the wide-angle view, and a shape and appearance module configured for selecting one or more objects in the wide-angle view based on descriptors that are scale and rotational invariant; and a region of interest selector for selecting a viewpoint from the wide-angle view based on output from at least one of the motion analysis module, the activity analysis module, and the shape and appearance module, wherein the region of interest selector outputs the selected viewpoint for display. The system further comprises at least one audio recording device for capturing audio from the event; and means for synchronizing the video images and audio. | 11-19-2009 |
20130182119 | APPARATUS FOR INTELLIGENT AND AUTONOMOUS VIDEO CONTENT GENERATION AND STREAMING - A system for automatically capturing an event of interest in a venue is disclosed, comprising a plurality of cameras for capturing video images of the event; and at least one processor communicatively connected to said plurality of cameras and configured to execute a plurality of modules, said modules comprising a rectification module for combining the video images to form a wide-angle view; at least one of a motion analysis module configured for tracking salient blobs that are not part of a background of the wide-angle view, an activity analysis module configured for extracting temporal and spatial patterns from the wide-angle view, and a shape and appearance module configured for selecting one or more objects in the wide-angle view based on descriptors that are scale and rotational invariant; and a region of interest selector for selecting a viewpoint from the wide-angle view based on output from at least one of the motion analysis module, the activity analysis module, and the shape and appearance module, wherein the region of interest selector outputs the selected viewpoint for display. The system further comprises at least one audio recording device for capturing audio from the event; and means for synchronizing the video images and audio. | 07-18-2013 |
Sarah Paule, Clayton AU
Patent application number | Description | Published |
---|---|---|
20090215669 | COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETES - The present invention relates to a composition comprising a peptide of the formula: (Xaa) | 08-27-2009 |
Sarah Piket, Maple Grove, MN US
Patent application number | Description | Published |
---|---|---|
20110153406 | Tracking and Processing Discount Cards - In one example, a stored value card system is modified to process discount cards that are capable of providing varying percentage discounts on an array of products or services that can be purchased by a consumer. Implementations of the stored value card system can include modifications that allow a transaction using the discount card to pass through as an authorized transaction in spite of, for instance, application software logic that otherwise rejects transactions for stored value cards having a zero balance. For example, when the modified stored value card system detects a transaction involving a discount card, an authorization system within the modified stored value card system can generate an alternative error code that prevents the point of sale system from rejecting the transaction due to a zero balance. | 06-23-2011 |
Sarah Prinsloo, Las Vegas, NV US
Patent application number | Description | Published |
---|---|---|
20100247841 | MAT CONFIGURATION - A mat configuration is configured of a substrate and a cover. The substrate has a top surface and a bottom surface, the bottom surface having a peripheral portion that includes an array of fasteners made from substrate material and acting as “buttons” with respect to slits formed in an underlying portion of the cover to hold the cover in place on the substrate. The fasteners can be achieved through various embodiments of indented or protruded elements on the substrate. The cover can be repeatedly attached and detached, and preferably, is made of material that is hand washable, washable in a standard washing machine or dry cleanable. The substrate is washable with soap and water. | 09-30-2010 |
Sarah Richardson-Burns, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20090292325 | HYBRID BIOELECTRICAL INTERFACE DEVICE - A hybrid bioelectrical interface (HBI) device can be an implantable device comprising an abiotic component operable to transmit charge via electrons or ions; a biological component interfacing with the neural tissue, the biological component being sourced from biologic, biologically-derived, or bio-functionalized material; and a conjugated polymer component that together provide a means to chronically interface living neural tissue with electronic devices for extended durations (e.g. greater than 10 years). In some embodiments, conjugated polymers provide a functional electrical interface for charge transfer and signal transduction between the nervous system and an electronic device (e.g. robotic prosthetic limb, retinal implant, microchip). | 11-26-2009 |
20110087315 | CO-ELECTRODEPOSITED HYDROGEL-CONDUCTING POLYMER ELECTRODES FOR BIOMEDICAL APPLICATIONS - Bioelectrodes having enhanced biocompatible and biomimetic features are provided. Methods of making and using the bioelectrodes are further provided. A biologically integrated bioelectrode device and method for detecting electronic signals using a bioelectrode comprising a first electrically conductive substrate and a biological component. The bioelectrode also comprises a conductive polymer electrically coupling the first electrically conductive substrate and the biological component to define a bioelectrode. The bioelectrode can transmit or receive an electrical signal between the electrically conductive substrate and the biological component and conductive polymer. | 04-14-2011 |
20110257504 | BIOLOGICALLY INTEGRATED ELECTRODE DEVICES - Bioelectrodes having enhanced biocompatible and biomimetic features are provided. Methods of making and using the bioelectrodes are further provided. A biologically integrated bioelectrode device and method for detecting electronic signals using a bioelectrode comprising a first electrically conductive substrate and a biological component. The bioelectrode also comprises a conductive polymer electrically coupling the first electrically conductive substrate and the biological component to define a bioelectrode. The bioelectrode can transmit or receive an electrical signal between the electrically conductive substrate and the biological component and conductive polymer. | 10-20-2011 |
20110301677 | ELECTRICALLY CONDUCTIVE AND MECHANICALLY SUPPORTIVE MATERIALS FOR BIOMEDICAL LEADS - An implantable medical lead connecting to a device header of a medical apparatus and having an electrode, a conductor, and a conductive polymer layer formed on at least a portion of the medical lead. An insulative sheath surrounds the conductive polymer layer for electrical insulation. The conductive polymer layer and insulative sheath maintain mechanical and electrical continuity of the lead in the event of fracture. The conductive polymer layer is composed of conductive polymers and may contain one or more dopants for improving electrical characteristics, mechanical characteristics, and processability. | 12-08-2011 |
20140058489 | ELECTRICALLY CONDUCTIVE AND MECHANICALLY SUPPORTIVE POLYMER MATERIALS FOR BIOMEDICAL LEADS - An implantable medical lead connecting to a device header of a medical apparatus and having an electrode, a conductor, and a conductive polymer layer formed on at least a portion of the medical lead. An insulative sheath surrounds the conductive polymer layer for electrical insulation. The conductive polymer layer and insulative sheath maintain mechanical and electrical continuity of the lead in the event of fracture. The conductive polymer layer is composed of conductive polymers and may contain one or more dopants for improving electrical characteristics, mechanical characteristics, and processability. | 02-27-2014 |
20140249645 | HYBRID BIOELECTRICAL INTERFACE DEVICE - A hybrid bioelectrical interface (HBI) device can be an implantable device comprising an abiotic component operable to transmit charge via electrons or ions; a biological component interfacing with the neural tissue, the biological component being sourced from biologic, biologically-derived, or bio-functionalized material; and a conjugated polymer component that together provide a means to chronically interface living neural tissue with electronic devices for extended durations (e.g. greater than 10 years). In some embodiments, conjugated polymers provide a functional electrical interface for charge transfer and signal transduction between the nervous system and an electronic device (e.g. robotic prosthetic limb, retinal implant, microchip). | 09-04-2014 |
20140277318 | IMPLANTABLE ELECTRODE COMPRISING A CONDUCTIVE POLYMERIC COATING - The present invention generally relates to coated electrodes comprising an electrically conductive substrate and a polymeric coating, and to methods for the preparation of the same. | 09-18-2014 |
Sarah Rieubland, London GB
Patent application number | Description | Published |
---|---|---|
20100321449 | CONTINUOUS INKJET PRINTING - A continuous inkjet method in which liquid passes through a nozzle, the liquid being jetted comprising one or more dispersed or particulate components and where the particle Peclet number, Pe, defined by | 12-23-2010 |
Sarah Ritthaler, Scottsdale, AZ US
Patent application number | Description | Published |
---|---|---|
20080302866 | METHOD FOR CREATING A LABEL, COMPUTER PROGRAM PRODUCT AND LOGISTICS SYSTEM - There is provided a method and logistics system for creating a label. An exemplary method comprises creating allowance information to allow an original receiver to enter shipment information and allowing the original receiver to activate an option to create a return label. The exemplary method further comprises enabling the original receiver of the item to print the return label. | 12-11-2008 |
Sarah Roberts-Thomson, Queensland AU
Patent application number | Description | Published |
---|---|---|
20100119518 | TARGET FOR BREAST CANCER THERAPY AND/OR DIAGNOSIS - The present invention relates to breast cancer and methods for identifying therapeutics and diagnosis. In general, methods for identifying therapeutic agents directed to calcium flow arc disclosed. Also provided arc methods for diagnosis of breast cancer and/or a predisposition to breast cancer and methods of treatment of breast cancer. The methods include identifying therapeutic agents which modulate a CRAC channel and/or a glycoprotein activator of a CRAC channel. Also provided arc diagnostic methods that ultilise a CRAC channel and/or a glycoprotein activator of a CRAC channel. | 05-13-2010 |
20130252838 | TARGET FOR BREAST CANCER THEREAPY AND/OR DIAGNOSIS - The present invention relates to breast cancer and methods for identifying therapeutics and diagnosis. In general, methods for identifying therapeutic agents directed to calcium flow are disclosed. Also provided are methods for diagnosis of breast cancer and/or a predisposition to breast cancer and methods of treatment of breast cancer. The methods include identifying therapeutic agents which modulate a CRAC channel and/or a glycoprotein activator of a CRAC channel. Also provided are diagnostic methods that utilise a CRAC channel and/or a glycoprotein activator of a CRAC channel. | 09-26-2013 |
Sarah Sague, Radnor, PA US
Patent application number | Description | Published |
---|---|---|
20090117104 | GLP-2 Mimetibodies, Polypeptides, Compositions, Methods and Uses - Mammalian GLP-2 mimetibodies, polypeptides and nucleic acids are disclosed. Methods of utilizing the mimetibodies and polypeptides to treat GLP-2 related diseases are also disclosed. | 05-07-2009 |
20110091378 | Methods and Compositions for Treating Fibrosis Related Disorders Using IL-17 Antagonists - The present invention relates methods and compositions for treating interleukin-17 (IL-17) related conditions, such as IL-17A or IL-17F, or muteins thereof in patients having fibrosis using IL-17 antagonists, such as small molecule IL-17 antagonists or protein IL-17 antagonists, such as antibodies, including specified portions or variants, specific for at least one IL-17 protein, mutein or fragment thereof, including therapeutic formulations, administration and devices. | 04-21-2011 |
Sarah Schmitz, Dusseldorf DE
Patent application number | Description | Published |
---|---|---|
20100010244 | Method For Producing Fatty Acid Alkanol Amides - The invention relates to a method for producing fatty acid alkanol amides by reacting at least one amine that contains at least one primary or secondary amino group and at least one hydroxyl group with at least one fatty acid to form an ammonium salt, said ammonium salt being subsequently converted into the alkanol amide by means of microwave radiation. | 01-14-2010 |
Sarah Schmitz, Essen DE
Patent application number | Description | Published |
---|---|---|
20110015290 | USE OF METAL SALTS OF A CARBOXYLIC ACID IN THE PRODUCTION OF POLYURETHANE SYSTEMS - A catalyst system which is suitable for catalyzing the production of polyurethane systems is provided. The catalyst system contains a metal salt of a carboxylic acid to whose carbonyl carbon a hydrogen atom or a hydrocarbon radical is bound, with the proviso that the carboxylic acid does not have exclusively a single ethyl or n-propyl branch in the 2 position. | 01-20-2011 |
20110054055 | LOW-PHOSPHORUS LAMINATION ADDITIVES HAVING LOW EMISSION, IMPROVED INITIAL ADHESION AND IMPROVED HYDROLYSIS STABILITY - A composition is provided which is suitable for producing polyurethane systems appropriate for hot adhesive bonding. The composition includes from 0.1 to 20% by mass of an additive mixture comprising at least one organic phosphorus compound either alone or in combination with a crosslinker or extender. | 03-03-2011 |
20120190760 | SILICONE-POLYETHER BLOCK COPOLYMERS WITH HIGH MOLECULAR WEIGHT POLYETHER RESIDUES AND THEIR USE AS STABILIZERS FOR PRODUCTION OF POLYURETHANE FOAMS - Silicone-polyether block copolymer comprising a polyorganosiloxane which includes at least one polyether residue having a molecular weight of not less than 5000 g/mol, and wherein a weight average molecular weight of all polyether residues attached to the polyorganosiloxane by a chemical bond is above 3000 g/mol, its production and use and also compositions and polymeric articles obtained therewith. | 07-26-2012 |
20120190762 | USE OF SILICONE-POLYETHER BLOCK COPOLYMERS WITH HIGH MOLECULAR WEIGHT NON-ENDCAPPED POLYETHER MOIETIES AS STABILIZERS FOR PRODUCTION OF LOW-DENSITY POLYURETHANE FOAMS - A process for production of polyurethane foams having a density of below 24.0 kg/m | 07-26-2012 |
20140058004 | USE OF METAL SALTS OF A CARBOXYLIC ACID IN THE PRODUCTION OF POLYURETHANE SYSTEMS - A catalyst system which is suitable for catalyzing the production of polyurethane systems is provided. The catalyst system contains a metal salt of a carboxylic acid to whose carbonyl carbon a hydrogen atom or a hydrocarbon radical is bound, with the proviso that the carboxylic acid does not have exclusively a single ethyl or n-propyl branch in the 2 position. | 02-27-2014 |
Sarah Schmitz, Duesseldorf DE
Patent application number | Description | Published |
---|---|---|
20100032284 | Method For Producing Alkaline (Meth)Acrylamides - The invention relates to a method for producing alkaline amides or imides of ethylenically unsaturated C | 02-11-2010 |
20100116642 | Method For Producing Alkaline Fatty Acid Amides - The invention relates to a method for producing alkaline fatty acid amides by reacting at least one amine that contains at least one primary or secondary amino group and at least one tertiary amino group with at least one fatty acid to form an ammonium salt, said ammonium salt being subsequently converted into the alkaline amide by means of microwave radiation. | 05-13-2010 |
Sarah Schmitz, Duessldorf DE
Patent application number | Description | Published |
---|---|---|
20100081843 | Method For Producing Tertiary Amides Of Alkylphenyl Carboxylic Acids - The invention relates to a method for producing tertiary amides of alkylphenyl carboxylic acids by reacting at least one secondary amine with at least one alkylphenyl carboxylic acid to form an ammonium salt, said ammonium salt being subsequently converted into the tertiary amide by means of microwave radiation. | 04-01-2010 |
Sarah Schols, Kessel-Lo BE
Patent application number | Description | Published |
---|---|---|
20100230668 | Organic Light-Emitting Device with Field-Effect Enhanced Mobility - A two-terminal organic light-emitting device structure is presented with low absorption losses and high current densities. Light generation and emission occur at a predetermined distance from any metallic contact, thereby reducing optical absorption losses. High current densities and thus high emitted light intensity are achieved by combining two types of conduction in one device: by combining space charge limited conduction and field-effect conduction or by combining ohmic conduction and field-effect conduction, thereby optimizing the current densities. This results in a very high local concentration of excitons and therefore a high light intensity, which can be important for applications such as organic lasers, and more in particular electrically pumped organic lasers. | 09-16-2010 |
Sarah Schulz, Wulfrath DE
Patent application number | Description | Published |
---|---|---|
20100280209 | CURABLE COMPOUND COMPRISING SILYLATED POLYURETHANE - A method for producing a silylated polyurethane including the steps: (A) converting (i) at least polyol compound having a molecular weight of 4,000-30,000 g/mol and at least one monofunctional compound relative to isocyanates and (ii) at least one diisocyanate at a stoichiometric excess of the sum of the polyol compound(s) and monofunctional compound relative to the diisocyanate compound(s), whereby a hydroxyl-terminated polyurethane prepolymer is formed; and (B) converting the polyurethane prepolymer and one or more isocyanate silane(s) of the formula (I): OCN—R—Si—(R1) | 11-04-2010 |
Sarah Scocca, Milano IT
Patent application number | Description | Published |
---|---|---|
20090053317 | MICROPARTICULATE SYSTEMS FOR THE ORAL ADMINISTRATION OF BIOLOGICALLY ACTIVE SUBSTANCES - The present invention relates to gastroresistant and enterosoluble microparticulate systems for the encapsulation of biologically active substances selected from: flavonoids, vitamins, antioxidants, immunostimulants, starchy and non-starchy polysaccharides, probiotics, prebiotics, intestinal trophism regulators, oligoelements, enzymes and bioactive peptides. Such microparticulate systems allow the administration of the aforementioned nutraceutic substances to animals such as porcines, bovines, caprines, ovines, equids, canids, felines, camelids, lagomorphs, rodents, fowl, and other mammals, including humans, fish and crustaceans, increasing the bioavailability. | 02-26-2009 |
Sarah Sellke, West Lafayette, IN US
Patent application number | Description | Published |
---|---|---|
20100180045 | MANAGING MULTI-STEP RETRY REINITIALIZATION PROTOCOL FLOWS - In an embodiment, a server computer comprises service processing logic that implements a Multi Step Retry Reinitialization Protocol Flow, and a protocol-aware rate limiting unit configured to cause one or more processors to perform receiving a message from a client; determining whether the received client message is a start type of message that requests starting the Flow; in response to determining that the received client message is a start type of message, determining whether to provide the received client message to the service processing logic using a discriminating rate limiting process. As a result, service unavailability may be prevented by rate limiting start types of messages, thereby allowing services to finish processing in-process protocol flows, when large numbers of clients concurrently attempt to obtain the services. | 07-15-2010 |
Sarah Shivers, Louisville, OH US
Patent application number | Description | Published |
---|---|---|
20090295201 | Convertible Seating Unit - A convertible seating unit for a motor vehicle is provided. The convertible seating unit comprises a seat having an upper surface, a front edge and a rear edge. The convertible seating unit further includes a back support comprising a first back support panel and a second back support panel. Each of the first and second back support panels has a first edge and a second edge, and an upper surface and a lower surface. The second edge of the first back panel is hingeably connected to the first edge of the second back panel to define a first hinge axis. The first edge of the first back panel is hingeably connected to the seat proximate the rear edge of the seat to define a second hinge axis. | 12-03-2009 |
Sarah Silverman, Toronto CA
Patent application number | Description | Published |
---|---|---|
20080234237 | QUINOLONE AND TETRAHYDROQUINOLONE AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY - The present invention features quinolones, tetrahydroquinolines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions. | 09-25-2008 |
20100009975 | BENZOXAZINES, BENZOTHIAZINES, AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY - The present invention features benzoxazines, benzothiazines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions. | 01-14-2010 |
20120122855 | BENZOXAZINES, BENZOTHIAZINES, AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY - The present invention features benzoxazines, benzothiazines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions. | 05-17-2012 |
20140163016 | BENZOXAZINES, BENZOTHIAZINES, AND RELATED COMPOUNDS HAVING NOS INHIBITORY ACTIVITY - The present invention features benzoxazines, benzothiazines, and related compounds that inhibit nitric oxide synthase (NOS), particularly those that selectively inhibit neuronal nitric oxide synthase (nNOS) in preference to other NOS isoforms. The NOS inhibitors of the invention, alone or in combination with other pharmaceutically active agents, can be used for treating or preventing various medical conditions. | 06-12-2014 |
Sarah Snykers, Lede BE
Patent application number | Description | Published |
---|---|---|
20090130064 | DIFFERENTIATION OF STEM CELLS AND STABILIZATION OF PHENOTYPICAL PROPERTIES OF PRIMARY CELLS - Methods of inducing differentiation of stem cells and stem cells obtained are disclosed. A method for stabilizing the phenotype of isolated primary cells in vitro is disclosed. In both methods, a central role is played by histone deacetylase inhibitors. | 05-21-2009 |
20100278782 | DIFFERENTIATION OF RAT LIVER EPITHELIAL CELLS INTO HEPATOCYTE-LIKE CELLS - Methods for differentiation of cells of a rat liver epithelial (RLEC) cell line to hepatocyte-like cells are disclosed. In particular, methods involve sequential exposure of the RLEC to two or more differentiation agents. Cells obtained by the method are described as well as their uses in various pharmacological, toxicological, therapeutic, diagnostic and research applications. | 11-04-2010 |
Sarah Stobo Prichard, Highland Park, IL US
Patent application number | Description | Published |
---|---|---|
20110010101 | SIMPLIFIED PERITONEAL EQUILIBRATION TEST FOR PERITONEAL DIALYSIS - A simplified peritoneal equilibration test (S-PET) is disclosed. Instead of a lengthy peritoneal equilibration test (PET), the simplified procedure requires no blood sample and may use data from as few as two or three samples to classify a peritoneal membrane of a user. Typically, a peritoneal membrane or peritoneum of a dialysis patient, or other person, is classed as a high transport membrane, high-average transport membrane, a low-average transport membrane or a low transporter membrane. The S-PET may be performed at home by a user without the need to submit a blood sample. Kits for analyzing the samples may be furnished for home use. The kits may use disposable strips, microfluidic analyzers or chemical reagents, or may alternatively include reusable analysis equipment, such as optical or conductivity analysis equipment. | 01-13-2011 |
Sarah Strycharz, Alexandria, VA US
Patent application number | Description | Published |
---|---|---|
20100059436 | SYSTEMS AND METHODS FOR MICROBIAL REDUCTIVE DECHLORINATION OF ENVIRONMENTAL CONTAMINANTS - In preferred embodiments, bioremediation systems are provided that comprise electricigenic microbes that use electrons provided directly from the anode of an electrical bioremediation system to carry out reductive dehalogenation of halogenated hydrocarbon contaminants, including chlorinated solvents. The present invention also provides methods of performing in situ bioremediation of halogenated solvents in groundwater or soil through the use of the provided systems. | 03-11-2010 |
Sarah Surrall, Oxford GB
Patent application number | Description | Published |
---|---|---|
20110025519 | NON-INTRUSIVE UTILITY MONITORING - A method of outputting to a user an indication of the usage of a utility, the method comprising: obtaining data indicating, for each of a plurality of appliances, a respective current level of usage of the utility by that appliance; for each of a plurality of appliance categories, using the obtained data to calculate a respective current total level of usage of the utility by appliances belonging to that appliance category; and outputting an indication of the calculated current total level of usage of the utility for at least one of the plurality of appliance categories. | 02-03-2011 |
20130204399 | DETERMINING AN INDICATION OF A BACKGROUND LEVEL OF UTILITY CONSUMPTION - A non-intrusive method of determining, in respect of a group of appliances that are arranged to consume a utility, an indication of a background level of consumption of the utility by the group of appliances, the method comprising: receiving a series of utility values representative of a total level of consumption of the utility by the group of appliances; determining, based on the received utility values, an indication of a background level of consumption of the utility; and outputting the determined indication of the background level of consumption of the utility. | 08-08-2013 |
Sarah Suzanne, Montrond Les Bains FR
Patent application number | Description | Published |
---|---|---|
20110144797 | MACHINE FOR PERSONALISING CHIP CARDS AT A HIGH PROCESSING RATE - A machine for the personalising of chip cards ( | 06-16-2011 |
20110163157 | MACHINE FOR PERSONALISING SMART CARDS AT HIGH RATE - The personalisation machine for smart cards ( | 07-07-2011 |
Sarah Targett, Berkshire GB
Patent application number | Description | Published |
---|---|---|
20100331348 | TROPANE DERIVATIVES USEFUL AS PESTICIDES - Compounds of formula (I) wherein the substituents have the meanings assigned to them in claim | 12-30-2010 |
Sarah Teren, Madison, WI US
Patent application number | Description | Published |
---|---|---|
20110183357 | DEVICE AND METHODS FOR LIQUID CRYSTAL-BASED BIOAGENT DETECTION - The present invention provides liquid crystal-based devices and methods for bioagent detection. In certain aspects, the present invention is directed to devices and methods utilizing liquid crystals and membranes containing polymerized targets that can report the presence of bioagents including, but not limited to, enzymes, antibodies, and toxins. | 07-28-2011 |
Sarah Townshend, Mississauga CA
Patent application number | Description | Published |
---|---|---|
20090098517 | INTERACTIVE LANGUAGE APPARATUS - Disclosed is an interactive educational apparatus, ideally suitable for children. A set of symbol pieces, preferably in the form of letter blocks are provided. An interface board is provided for accommodating one or more selected symbol pieces and a sensor on said interface board generates a signal identifying each symbol piece when placed on said interface board. Media files are stored on a storage medium and each media file has an associated tag. A processor is programmed to match a search key represented by one or more selected symbol pieces with said tags. A display device displays one or more media files having identifier tags matching said search key represented by said selected symbol pieces. These identifier tags provide a means to match up the media files with each search key generated by placement of the symbol pieces on the interface board. | 04-16-2009 |
Sarah Tronet, Lannion FR
Patent application number | Description | Published |
---|---|---|
20100165966 | DYNAMIC APPROPRIATION OF AT LEAST ONE MULTIMEDIA DEVICE DURING CALL SET-UP - The invention relates to a method of dynamic appropriation of at least one second multimedia device by a first device situated in a geographical area in which said at least one second multimedia device is situated in the event of a request to set up a call between the first device and a third device, the method including a step of setting up a first signaling link between a server and the first device and a step of controlling the second and third devices from said server with a view to setting up between the second and third devices at least one first payload data stream forming a first part of said call. | 07-01-2010 |
Sarah Tullney, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20100015570 | PROCEDURE FOR DIMENSIONALLY ACCURATE SINTERING OF A SHAPED PIECE - A procedure for dimensionally accurate sintering of a shaped piece manufactured from a blank of porous ceramic material, in which during the sintering, the shaped piece remains connected via at least one first connection like a rib, with a support that is manufactured from the blank. To ensure with simple procedural steps and simple design measures that the geometry does not change during sintering, the invention provides that the support is manufactured as a section of the blank that at least in sections surrounds the shaped piece by materials removal processing from the blank, and after the manufacture, the support, for one, is connected via the at least one first connection with the shaped piece, and for another, via at least one second connection with the residual blank that in sections is separated from the support. | 01-21-2010 |
Sarah Ulmscheneider, Bad Duerkheim DE
Patent application number | Description | Published |
---|---|---|
20100130359 | Fungicidal Pyridazines, Processes for Their Preparation and Their Use for Controlling Harmful Fungi, and Compositions Comprising Them - Pyridazines of the formula I | 05-27-2010 |
Sarah Ulmschhneider, Dirmstein DE
Patent application number | Description | Published |
---|---|---|
20100267555 | Fungicidal mixtures II - The present invention relates to mixtures of fungicidally active compounds comprising at least one substituted 3-hydroxyl-3-(3-pyridyl)propanoate compound of the formula I | 10-21-2010 |
Sarah Vahove, Boutersem BE
Patent application number | Description | Published |
---|---|---|
20110024422 | CLOSURE - A closure having a base with a piercable part, defined by a sidewall extending transversally with respect to the base and a bottom thereby creating an indent therein, the sidewall and/or bottom provided with several lines of weakened material strength, wherein the lines divide the sidewall and/or bottom in several wedge formed parts. | 02-03-2011 |
Sarah Veelaert, Eppegem BE
Patent application number | Description | Published |
---|---|---|
20100330369 | PREGELATINIZED STARCHES AS CARRIER MATERIALS FOR LIQUID COMPONENTS - The present invention provides a liquid-loaded starch material comprising a solid carrier material consisting of pregelatinized, non-granular starch material which consists of flake-shaped starch particles, wherein the size distribution of the starch particles is such that at least 50% by weight of the starch particles have a particle size of between 100 and 375 μm, and wherein the BET specific surface area is less than or equal to 0.5 m | 12-30-2010 |
20110212149 | PUFFED STARCH MATERIAL - The present invention concerns a puffed popcorn starch containing powder having a loose bulk density of less than 120 g/L and a particle size smaller than 1 mm, a non-aqueous liquid-loaded starch material comprising said powder and a process for preparing these. In addition the present invention relates to the use of said powder as a solid carrier material for non-aqueous liquid or gaseous components and the use of said non-aqueous liquid-loaded starch material in food and animal feed products, pharmaceuticals, nutraceuticals, agrochemicals, and cosmetic or personal care products. | 09-01-2011 |
20120114788 | PARTICULATE FLAVOR DELIVERY SYSTEM, A METHOD OF MAKING IT AND USE THEREOF - A particulate flavour delivery system comprising a starch carrier and a blend of a first flavouring agent and a plasticizer, said first flavouring agent being non-liquid at a temperature of 20° C. to 25° C., and said plasticizer being liquid at a temperature of 20° C. to 25° C., said blend being encapsulated in said starch carrier, said encapsulated blend comprising at least 40% by weight of said blend, a portion of which is solid or semi-solid, said portion having a melting point or a glass transition temperature of from 25″C to 250° C., a method of making it, and use thereof. | 05-10-2012 |
20140287090 | PARTICULATE FLAVOR DELIVERY SYSTEM, A METHOD OF MAKING IT AND USE THEREOF - A particulate flavour delivery system comprising a starch carrier and a blend of a first flavouring agent and a plasticizer, said first flavouring agent being non-liquid at a temperature of 20° C. to 25° C., and said plasticizer being liquid at a temperature of 20° C. to 25° C., said blend being encapsulated in said starch carrier, said encapsulated blend comprising at least 40% by weight of said blend of a portion which is solid or semi-solid, said portion having a melting point or a glass transition temperature of from 25″C to 250° C., a method of making it and use thereof. | 09-25-2014 |
20150064329 | BAKERY FAT SYSTEM - The invention relates to a bakery fat system that is low in trans- and saturated fatty acids. A process for making the system of the present invention is also disclosed and a use in bakery applications, in particular in pastry applications, is also disclosed. In a first aspect, the present invention relates to a bakery fat system comprising from 30 weight/weight % (w/w %) to 75 w/w %, of a lipid and from 25 w/w % t 70 w/w % of a porous edible particle, characterized in that said bakery fat system is a structured fat system wherein the lipid is present as a continuous phase. In a second aspect, the present invention relates to a process for making the bakery fat system, a bakery product comprising the bakery fat system and further bakery ingredients, and the use of the bakery fat system in bakery applications, in particular in pastry applications, are also disclosed. | 03-05-2015 |
Sarah Venhuis, Hamilton CA
Patent application number | Description | Published |
---|---|---|
20110176987 | Transfer apparatus and system, and uses thereof - A transfer apparatus for facilitating transfer between a higher density fluid and a lower density fluid. The apparatus includes a transfer chamber includes a higher density fluid zone and a lower density fluid zone adjacent each other. A moveable contactor is housed in the transfer chamber. At least a portion of the moveable contactor is moveable between the higher density fluid zone and the lower density fluid zone. A current generator connected to the transfer chamber generates a current in the lower density fluid zone. A transfer system includes a plurality of fluidly connected apparatuses in series. | 07-21-2011 |
Sarah Vial, Abingdon GB
Patent application number | Description | Published |
---|---|---|
20110171714 | CRYSTAL STRUCTURE OF TAK1-TAB1 - The invention relates to molecules or molecular complexes which comprise binding pockets of TAK1 or its structural homologues. The invention relates to crystallizable compositions and crystals comprising TAK1. The present invention also relates to a data storage medium encoded with the structural coordinates of molecules and molecular complexes which comprise the TAK1 or TAK1-like ATP-binding pockets. The present invention also relates to a computer comprising such data storage material. The computer may generate a three-dimensional structure or graphical three-dimensional representation of such molecules or molecular complexes. This invention also relates to methods of using the structure coordinates to solve the structure of homologous proteins or protein complexes. In addition, this invention relates to methods of using the structure coordinates to screen for and design compounds, including inhibitory compounds, that bind to TAK1 or homologues thereof. | 07-14-2011 |
Sarah Wally, Waldwick, NJ US
Patent application number | Description | Published |
---|---|---|
20100034935 | PRECISION TEMPERATURE COOKING SYSTEM AND METHOD - A precision temperature cooking system for cooking food products in a facility includes a vacuum packaging device to package the food products in vacuum-sealable bags, and a heated water bath or a heated water circulator to maintain a water bath at a cooking temperature that is substantially equal to a desired final temperature of a core portion of the food products, and a chilling/freezing system to blast-chill or flash-freeze the food products cooked by the water bath, and a refrigerated storage device to receive and store the frozen food products from the blast-chiller, and a high-temperature finishing component configured to impart a desired appearance to the outside of the cooked food product. | 02-11-2010 |
Sarah Weisman, Griffith AU
Patent application number | Description | Published |
---|---|---|
20100100975 | SILK PROTEINS - The present invention provides silk proteins, as well as nucleic acids encoding these proteins. The present invention also provides recombinant cells and/or organisms which synthesize silk proteins. Silk proteins of the invention can be used for a variety of purposes such as in the manufacture of personal care products, plastics, textiles, and biomedical products. | 04-22-2010 |
20120245103 | Silk Proteins - The present invention provides silk proteins, as well as nucleic acids encoding these proteins. The present invention also provides recombinant cells and/or organisms which synthesize silk proteins. Silk proteins of the invention can be used for a variety of purposes such as in the manufacture of personal care products, plastics, textiles, and biomedical products. | 09-27-2012 |
20120302734 | Processes for Producing Silk Dope - The present invention relates to methods of producing silk dope comprising silk proteins with a coiled-coil structure such as honeybee silk proteins. The silk proteins are obtained from cells producing them, solubilising the proteins by contacting them with a surfactant or an ionic liquid and concentrating the proteins to produce silk dope. The proteins can be used for a variety of purposes such as in the production of personal care products, plastics, textiles and biomedical products. | 11-29-2012 |
20140288009 | Collagen-like Silk Genes - The present invention relates to silk proteins which can be used to produce silk with a collagen-like structure, as well as nucleic acids encoding such proteins. The present invention also relates to recombinant cells and/or organisms which synthesize silk proteins. Silk proteins of the invention can be used for a variety of purposes such as in the production of personal care products, plastics, textiles, and biomedical products. | 09-25-2014 |
Sarah Weisman, Australian Capital Territory AU
Patent application number | Description | Published |
---|---|---|
20110177997 | Cross-Beta Silk Genes - The present invention relates to silk proteins which can be used to produce silk with a cross-beta structure, as well as nucleic acids encoding such proteins. The present invention also relates to recombinant cells and/or organisms which synthesize silk proteins. Silk proteins of the invention can be used for a variety of purposes such as in the production of personal care products, plastics, textiles, and biomedical products. | 07-21-2011 |
Sarah Williams Gerber, Colorado Springs, CO US
Patent application number | Description | Published |
---|---|---|
20080307488 | Systems And Methods For Enterprise Security With Collaborative Peer To Peer Architecture - Systems and methods authenticate a device to operate within an enterprise system with an enterprise policy. An agent, installed on the device, analyzes the device to determine profile information of the device. The determined profile information is sent to a type 2 super peer that verifies whether the profile information conforms to the enterprise policy. If the profile information conforms to the enterprise policy, an agent trust credential is generated, within the type 2 super peer, for the agent, based upon the profile information, and issued to the agent. Authenticity of the device is verified based upon the agent trust credential. If the device is authenticated, communications with the device are permitted. If the device is not authenticated, communications with the device is prevented. In another embodiment, a method restores a device to conform to a system policy. A snapshot of critical components of the device is taken while the device is in compliance with the system policy. The critical components are monitored to identify critical components that differ from the critical components of the snapshot. If differing critical components are detected, the device is restored to conform with system policy by replacing differing critical components based upon the snapshot. | 12-11-2008 |
Sarah Wright, San Francisco, CA US
Patent application number | Description | Published |
---|---|---|
20090220505 | METHODS OF INHIBITING AMYLOID TOXICITY - The present invention features methods and compositions for inhibiting amyloidogenic protein toxicity, inhibiting formation of an amyloidogenic protein deposit and/or treating amyloidogenic diseases by administering a pharmaceutically effective amount of one or more agents that bind an integrin or an integrin subunit. | 09-03-2009 |
20100303824 | SIGNALING INTERMEDIATES IN AN IN VITRO MODEL OF ALZHEIMER'S DISEASE - The invention provides a novel human protein, FISH adaptor protein, involved in amyloid β-protein-mediated cell death. Also provided are methods for modulating amyloid β-protein-mediated cell death using agents that interfere with the activity of FISH adaptor protein. | 12-02-2010 |
20130036481 | USE OF PERLECAN DOMAIN V IN TREATING AMYLOIDOGENIC DISEASE - The application reports that perlecan domain V (DV) or the LG3 domain thereof reduces deposition and toxicity of Aβ peptide, the major component of plaques in Alzheimer's disease. Methods of using DV, LG3 and related molecules in treatment of amyloidogenic diseases, particularly Alzheimer's disease, are provided. | 02-07-2013 |
Sarah Wykes, Anhui CN
Patent application number | Description | Published |
---|---|---|
20110034293 | TRANSMISSION - A transmission includes an input shaft (IP), an output shaft (OP), a single planetary gearset (SP), a compound planetary gearset (CP), shifting elements. The single planetary gearset is arranged before the compound planetary gearset, and the shifting elements comprise at least two brakes (B | 02-10-2011 |